Hospital or health organisation · founded 1891
Methodist Hospital
Omaha, United States · bestcare.org/methodist-hospital
- Citations, last 5 years
- 902
- Works, last 5 years
- 74
- h-index
- 81
- Scientists listed
- 0
- Grants since 2016
- 211
Grants received
2017–2018 · research · R21
Integrative Analysis of Cancer Single-cell Transcriptomic and Functional Proteomic Data (2 of 2)
Lidong Qin · Methodist Hospital · funded by National Institutes of Health
2017–2022 · research · R01
Modulation of tumor inflammatory factor for immune therapy
Shu-Hsia Chen · Methodist Hospital · funded by National Institutes of Health
2017–2018 · research · R56
The adaptor protein Crk in immune responses
Dongfang Liu · Methodist Hospital · funded by National Institutes of Health
2017–2022 · research · R01
The Germ Cell Gene TDRD1 as a Novel Prostate Cancer Biomarker
Bin He · Methodist Hospital · funded by National Institutes of Health
2017–2022 · research · R01
T cell co-stimulation in obesity-induced adipose inflammation
Tuo Deng · Methodist Hospital · funded by National Institutes of Health
2017–2022 · research · R01
A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formation
Nhat-Tu Le · Methodist Hospital · funded by National Institutes of Health
2017–2025 · research · R01
Learning-Based Approach for Personalized Craniomaxillofacial Surgical Planning
Jaime Gateno · Methodist Hospital · funded by National Institutes of Health
2017–2020 · research · R56
Biomimetic nanovesicles to overcome multiple physiological barriers for primary and metastatic triple negative breast cancer therapy
Jenny C-N Chang · Methodist Hospital · funded by National Institutes of Health
2016–2020 · research · R01
Functional characterization of brain-colonizing breast cancer CTC subsets
Dario Marchetti · Methodist Hospital · funded by National Institutes of Health
2016–2022 · research · R01
Molecular Regulation of Long-term Immune Memory
Jin Wang · Methodist Hospital · funded by National Institutes of Health
2016–2024 · research · R01
LILRB modulates tumor microenvironment and promotes tumor progression
Shu-Hsia Chen · Methodist Hospital · funded by National Institutes of Health
2016–2020 · research · R01
High Density Lipoprotein Biogenesis and Speciation
Henry J. Pownall · Methodist Hospital · funded by National Institutes of Health
2016–2022 · cooperative agreement · U54
Center for Immunotherapeutic Transport Oncophysics
Jenny C-N Chang · Methodist Hospital · funded by National Institutes of Health
2016–2021 · cooperative agreement · U54
Center for Immunotherapeutic Transport Oncophysics
Jenny C-N Chang · Methodist Hospital · funded by National Institutes of Health
2016–2021 · research · R01
Molecular Regulation of Long-term Immune Memory
Jin Wang · Methodist Hospital · funded by National Institutes of Health
2016–2021 · cooperative agreement · U54
Center for Immunotherapeutic Transport Oncophysics
Mauro Ferrari · Methodist Hospital · funded by National Institutes of Health
2016 · research · R01
Quantification of Circulating Antigens for Pediatric TB Diagnosis and Treatment Monitoring
Tony Y. Hu · Methodist Hospital · funded by National Institutes of Health
2016–2021 · research · R01
A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis
Alessandro Grattoni · Methodist Hospital · funded by National Institutes of Health
2016–2020 · research · R01
MOLECULAR REGULATION OF IMMUNITY TO VIRAL INFECTIONS
Jin Wang · Methodist Hospital · funded by National Institutes of Health
2016–2020 · research · R01
Functional characterization of brain-colonizing breast cancer CTC subsets
Dario Marchetti · Methodist Hospital · funded by National Institutes of Health
2016–2026 · research · R01
The Impact of Sleep on Network Coding and Perceptual Performance
Valentin Dragoi · Methodist Hospital · funded by National Institutes of Health
2016–2026 · career development · K24
POR and Training Program on Multidrug-Resistant Organisms
Cesar Augusto Arias · Methodist Hospital · funded by National Institutes of Health
2016–2022 · cooperative agreement · U54
Microenvironmental Transport for Immunotherapy in Pancreatic Cancer
Rolf A Brekken · Methodist Hospital · funded by National Institutes of Health
2015–2020 · cooperative agreement · U01
Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy
Vivek Mittal · Methodist Hospital · funded by National Institutes of Health
2015–2020 · research · R01
Molecular mechanism of virulence regulation in Streptococcus pyogenes
Muthiah Kumaraswami · Methodist Hospital · funded by National Institutes of Health
2015–2022 · research · R01
Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma
Jing Yang · Methodist Hospital · funded by National Institutes of Health
2015–2022 · cooperative agreement · U01
Integrative molecular and imaging approaches for risk of subtype specific breast
Isabelle Bedrosian · Methodist Hospital · funded by National Institutes of Health
2015–2021 · research · R01
Therapeutically relevant targets of Twist1 dimers in glioma
Robert C Rostomily · Methodist Hospital · funded by National Institutes of Health
2015–2021 · research · R01
Molecular mechanism of virulence regulation in Streptococcus pyogenes
Muthiah Kumaraswami · Methodist Hospital · funded by National Institutes of Health
2015–2022 · research · R01
Tumor vasculature-targeted nanotherapeutics for DNA damage response
Haifa Shen · Methodist Hospital · funded by National Institutes of Health
2015–2020 · cooperative agreement · U01
Integrative molecular and imaging approaches for risk of subtype specific breast
Isabelle Bedrosian · Methodist Hospital · funded by National Institutes of Health
2015–2021 · research · R01
Therapeutically relevant targets of Twist1 dimers in glioma
Robert C Rostomily · Methodist Hospital · funded by National Institutes of Health
2015–2020 · cooperative agreement · U01
Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy
Vivek Mittal · Methodist Hospital · funded by National Institutes of Health
2015–2021 · research · R01
Therapeutically relevant targets of Twist1 dimers in glioma
Robert C Rostomily · Methodist Hospital · funded by National Institutes of Health
2015–2020 · cooperative agreement · U01
Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy
Vivek Mittal · Methodist Hospital · funded by National Institutes of Health
2014–2026 · research · R01
Control of dysfunctional Tregs
Xian Chang Li · Methodist Hospital · funded by National Institutes of Health
2014–2027 · research · R01
Control of dysfunctional Tregs
Xian Chang Li · Methodist Hospital · funded by National Institutes of Health
2013–2025 · research · R01
Outcome-Driven Approach to Minimize the Risks of Facial Distortion Following CMF Surgery
James J Xia · Methodist Hospital · funded by National Institutes of Health
2013–2020 · research · R00
The steroid receptor coactivator SRC-2 coordinates and modulates the metabolic, s
Erin L Reineke · Methodist Hospital · funded by National Institutes of Health
2013–2026 · research · R01
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches
Keith Syson Chan · Methodist Hospital · funded by National Institutes of Health